O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	14	16	IL	IL	B-NP	NN	B-protein	6	NMOD	B-protein
T1	I-Protein	16	17	-	-	O	HYPH	I-protein	6	NMOD	I-protein
T1	I-Protein	17	18	6	6	B-NP	CD	I-protein	6	NMOD	I-protein
O	O	19	28	synthesis	synthesis	I-NP	NN	O	2	PMOD	O
O	O	29	31	in	in	B-PP	IN	O	1	NMOD	O
O	O	32	37	human	human	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	38	48	peripheral	peripheral	I-NP	JJ	I-cell_type	12	NMOD	I-cell_type
O	O	49	54	blood	blood	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	55	66	mononuclear	mononuclear	I-NP	JJ	I-cell_type	12	NMOD	I-cell_type
O	O	67	72	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	73	75	by	by	B-PP	IN	O	1	NMOD	O
T2	B-Protein	76	79	C3a	C3a	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	80	83	and	and	O	CC	O	18	NMOD	O
T3	B-Protein	84	87	C3a	C3a	B-NP	NN	B-protein	18	NMOD	B-protein
T3	I-Protein	87	88	(	(	O	(	I-protein	18	NMOD	I-protein
T3	I-Protein	88	94	desArg	desArg	B-NP	NN	I-protein	13	PMOD	I-protein
T3	I-Protein	94	95	)	)	O	)	I-protein	18	NMOD	I-protein
O	O	95	96	.	.	O	.	O	1	P	O

O	O	98	101	The	The	B-NP	DT	O	3	NMOD	O
O	O	102	115	anaphylatoxin	anaphylatoxin	I-NP	NN	B-protein	3	NMOD	B-protein
T4	B-Protein	116	119	C3a	C3a	I-NP	NN	B-protein	4	SUB	B-protein
O	O	120	123	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	124	128	been	be	I-VP	VBN	O	4	VC	O
O	O	129	137	reported	report	I-VP	VBN	O	5	VC	O
O	O	138	140	to	to	I-VP	TO	O	8	VMOD	O
O	O	141	145	have	have	I-VP	VB	O	6	VMOD	O
O	O	146	162	immunomodulatory	immunomodulatory	B-NP	JJ	O	10	NMOD	O
O	O	163	170	effects	effect	I-NP	NNS	O	8	OBJ	O
O	O	171	173	on	on	B-PP	IN	O	8	VMOD	O
O	O	174	175	a	a	B-NP	DT	O	13	NMOD	O
O	O	176	182	number	number	I-NP	NN	O	11	PMOD	O
O	O	183	185	of	of	B-PP	IN	O	13	NMOD	O
O	O	186	195	different	different	B-NP	JJ	O	17	NMOD	O
O	O	196	200	cell	cell	I-NP	NN	O	17	NMOD	O
O	O	201	206	types	type	I-NP	NNS	O	14	PMOD	O
O	O	206	207	.	.	O	.	O	4	P	O

O	O	208	210	In	In	B-PP	IN	O	5	VMOD	O
O	O	211	215	this	this	B-NP	DT	O	3	NMOD	O
O	O	216	221	study	study	I-NP	NN	O	1	PMOD	O
O	O	222	224	we	we	B-NP	PRP	O	5	SUB	O
O	O	225	237	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	238	241	the	the	B-NP	DT	O	7	NMOD	O
O	O	242	249	effects	effect	I-NP	NNS	O	5	OBJ	O
O	O	250	252	of	of	B-PP	IN	O	7	NMOD	O
T5	B-Protein	253	256	C3a	C3a	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	257	260	and	and	O	CC	O	13	NMOD	O
T6	B-Protein	261	264	C3a	C3a	B-NP	NN	B-protein	13	NMOD	B-protein
T6	I-Protein	264	265	(	(	O	(	I-protein	13	NMOD	I-protein
T6	I-Protein	265	271	desArg	desArg	B-NP	NN	I-protein	8	PMOD	I-protein
T6	I-Protein	271	272	)	)	O	)	I-protein	13	NMOD	I-protein
O	O	273	275	on	on	B-PP	IN	O	7	NMOD	O
O	O	276	280	gene	gene	B-NP	NN	O	17	NMOD	O
O	O	281	291	expression	expression	B-NP	NN	O	20	NMOD	O
O	O	292	295	and	and	O	CC	O	20	NMOD	O
O	O	296	303	protein	protein	B-NP	NN	O	20	NMOD	O
O	O	304	313	secretion	secretion	I-NP	NN	O	15	PMOD	O
O	O	314	316	of	of	B-PP	IN	O	20	NMOD	O
T7	B-Protein	317	319	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T7	I-Protein	319	320	-	-	B-NP	HYPH	I-protein	21	PMOD	I-protein
T7	I-Protein	320	321	6	6	I-NP	CD	I-protein	23	NMOD	I-protein
O	O	322	324	in	in	B-PP	IN	O	20	NMOD	O
O	O	325	330	human	human	B-NP	JJ	O	25	PMOD	O
O	O	331	336	PBMCs	PBMC	I-NP	NNS	B-cell_type	26	NMOD	B-cell_type
O	O	336	337	,	,	O	,	O	20	P	O
O	O	338	344	either	either	O	CC	O	20	NMOD	O
O	O	345	350	alone	alone	B-ADVP	RB	O	29	DEP	O
O	O	351	353	or	or	O	CC	O	29	DEP	O
O	O	354	356	in	in	B-PP	IN	O	29	DEP	O
O	O	357	368	combination	combination	B-NP	NN	O	32	PMOD	O
O	O	369	373	with	with	B-PP	IN	O	33	NMOD	O
O	O	374	377	LPS	LPS	B-NP	NN	O	39	NMOD	O
O	O	378	380	or	or	I-NP	CC	O	39	NMOD	O
T8	B-Protein	381	383	IL	IL	I-NP	NN	B-protein	39	NMOD	B-protein
T8	I-Protein	383	384	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
T8	I-Protein	384	389	1beta	1beta	I-NP	NN	I-protein	34	PMOD	I-protein
O	O	389	390	.	.	O	.	O	5	P	O

T9	B-Protein	391	394	C3a	C3a	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	395	397	or	or	I-NP	CC	O	5	NMOD	O
T10	B-Protein	398	401	C3a	C3a	I-NP	NN	B-protein	5	NMOD	B-protein
T10	I-Protein	401	402	(	(	O	(	I-protein	5	NMOD	I-protein
T10	I-Protein	402	408	desArg	desArg	B-NP	NN	I-protein	8	SUB	I-protein
T10	I-Protein	408	409	)	)	O	)	I-protein	5	NMOD	I-protein
O	O	410	415	alone	alone	B-ADVP	RB	O	5	NMOD	O
O	O	416	425	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	426	428	no	no	B-NP	DT	O	10	NMOD	O
O	O	429	435	effect	effect	I-NP	NN	O	8	OBJ	O
O	O	436	438	on	on	B-PP	IN	O	8	VMOD	O
O	O	439	442	the	the	B-NP	DT	O	15	NMOD	O
O	O	443	453	expression	expression	I-NP	NN	O	15	NMOD	O
O	O	454	456	or	or	I-NP	CC	O	15	NMOD	O
O	O	457	466	secretion	secretion	I-NP	NN	O	11	PMOD	O
O	O	467	469	of	of	B-PP	IN	O	15	NMOD	O
T11	B-Protein	470	472	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T11	I-Protein	472	473	-	-	B-NP	HYPH	I-protein	16	PMOD	I-protein
T11	I-Protein	473	474	6	6	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	474	475	.	.	O	.	O	8	P	O

O	O	476	483	However	However	B-ADVP	RB	O	21	VMOD	O
O	O	483	484	,	,	O	,	O	21	P	O
O	O	485	489	when	when	B-ADVP	WRB	O	21	VMOD	O
O	O	490	494	PBMC	PBMC	B-NP	NN	B-cell_type	5	SUB	B-cell_type
O	O	495	499	were	be	B-VP	VBD	O	3	SBAR	O
O	O	500	510	stimulated	stimulate	I-VP	VBN	O	5	VC	O
O	O	511	515	with	with	B-PP	IN	O	6	VMOD	O
O	O	516	519	LPS	LPS	B-NP	NN	O	12	NMOD	O
O	O	520	522	or	or	I-NP	CC	O	12	NMOD	O
T12	B-Protein	523	525	IL	IL	I-NP	NN	B-protein	12	NMOD	B-protein
T12	I-Protein	525	526	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T12	I-Protein	526	531	1beta	1beta	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	531	532	,	,	O	,	O	21	P	O
O	O	533	537	both	both	O	CC	O	19	NMOD	O
T13	B-Protein	538	541	C3a	C3a	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	542	545	and	and	O	CC	O	19	NMOD	O
T14	B-Protein	546	549	C3a	C3a	B-NP	NN	B-protein	19	NMOD	B-protein
T14	I-Protein	549	550	(	(	O	(	I-protein	19	NMOD	I-protein
T14	I-Protein	550	556	desArg	desArg	B-NP	NN	I-protein	21	SUB	I-protein
T14	I-Protein	556	557	)	)	O	)	I-protein	19	NMOD	I-protein
O	O	558	562	were	be	B-VP	VBD	O	0	ROOT	O
O	O	563	568	found	find	I-VP	VBN	O	21	VC	O
O	O	569	571	to	to	I-VP	TO	O	24	VMOD	O
O	O	572	579	enhance	enhance	I-VP	VB	O	22	VMOD	O
T15	B-Protein	580	582	IL	IL	B-NP	NN	B-protein	28	NMOD	B-protein
T15	I-Protein	582	583	-	-	I-NP	HYPH	I-protein	25	AMOD	I-protein
T15	I-Protein	583	584	6	6	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	585	592	release	release	I-NP	NN	O	24	OBJ	O
O	O	593	595	by	by	B-PP	IN	O	28	NMOD	O
O	O	596	600	PBMC	PBMC	B-NP	NN	B-cell_type	29	PMOD	B-cell_type
O	O	601	603	in	in	B-PP	IN	O	28	NMOD	O
O	O	604	605	a	a	B-NP	DT	O	36	NMOD	O
O	O	606	610	dose	dose	I-NP	NN	O	36	NMOD	O
O	O	610	611	-	-	B-NP	HYPH	O	36	NMOD	O
O	O	611	620	dependent	dependent	I-NP	JJ	O	36	NMOD	O
O	O	621	627	manner	manner	I-NP	NN	O	31	PMOD	O
O	O	627	628	.	.	O	.	O	21	P	O

O	O	629	634	Since	Since	B-SBAR	IN	O	15	VMOD	O
T16	B-Protein	635	638	C3a	C3a	B-NP	NN	B-protein	3	SUB	B-protein
O	O	639	642	has	have	B-VP	VBZ	O	1	SBAR	O
O	O	643	647	been	be	I-VP	VBN	O	3	VC	O
O	O	648	653	shown	show	I-VP	VBN	O	4	VC	O
O	O	654	656	to	to	I-VP	TO	O	7	VMOD	O
O	O	657	663	induce	induce	I-VP	VB	O	5	VMOD	O
O	O	664	668	PGE2	PGE2	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	669	679	production	production	I-NP	NN	O	7	OBJ	O
O	O	680	682	by	by	B-PP	IN	O	9	NMOD	O
O	O	683	692	monocytes	monocyte	B-NP	NNS	B-cell_type	10	PMOD	B-cell_type
O	O	692	693	,	,	O	,	O	15	P	O
O	O	694	697	and	and	O	CC	O	15	VMOD	O
O	O	698	702	PGE2	PGE2	B-NP	NN	B-protein	15	SUB	B-protein
O	O	703	706	has	have	B-VP	VBZ	O	24	VMOD	O
O	O	707	711	been	be	I-VP	VBN	O	15	VC	O
O	O	712	717	shown	show	I-VP	VBN	O	16	VC	O
O	O	718	720	to	to	I-VP	TO	O	19	VMOD	O
O	O	721	730	influence	influence	I-VP	VB	O	17	VMOD	O
O	O	731	739	cytokine	cytokine	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	740	750	production	production	I-NP	NN	O	19	OBJ	O
O	O	750	751	,	,	O	,	O	24	P	O
O	O	752	754	we	we	B-NP	PRP	O	24	SUB	O
O	O	755	767	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	768	771	the	the	B-NP	DT	O	27	NMOD	O
O	O	772	781	potential	potential	I-NP	JJ	O	27	NMOD	O
O	O	782	786	role	role	I-NP	NN	O	24	OBJ	O
O	O	787	789	of	of	B-PP	IN	O	27	NMOD	O
O	O	790	794	PGE2	PGE2	B-NP	NN	B-protein	28	PMOD	B-protein
O	O	795	797	in	in	B-PP	IN	O	27	NMOD	O
T17	B-Protein	798	801	C3a	C3a	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	801	802	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	802	810	mediated	mediate	I-NP	VBN	O	34	NMOD	O
O	O	811	822	enhancement	enhancement	I-NP	NN	O	30	PMOD	O
O	O	823	825	of	of	B-PP	IN	O	34	NMOD	O
O	O	826	829	LPS	LPS	B-NP	NN	O	47	NMOD	O
O	O	829	830	-	-	B-NP	HYPH	O	36	P	O
O	O	831	834	and	and	O	CC	O	47	NMOD	O
T18	B-Protein	835	837	IL	IL	B-NP	NN	B-protein	41	NMOD	B-protein
T18	I-Protein	837	838	-	-	B-NP	HYPH	I-protein	41	P	I-protein
T18	I-Protein	838	843	1beta	1beta	I-NP	NN	I-protein	47	NMOD	I-protein
O	O	843	844	-	-	O	HYPH	O	41	P	O
O	O	844	851	induced	induce	B-NP	VBN	O	47	NMOD	O
T19	B-Protein	852	854	IL	IL	I-NP	NN	B-protein	47	NMOD	B-protein
T19	I-Protein	854	855	-	-	O	HYPH	I-protein	47	NMOD	I-protein
T19	I-Protein	855	856	6	6	B-NP	CD	I-protein	47	NMOD	I-protein
O	O	857	867	production	production	I-NP	NN	O	35	PMOD	O
O	O	867	868	.	.	O	.	O	24	P	O

O	O	869	881	Indomethacin	Indomethacin	B-NP	NN	O	2	SUB	O
O	O	882	889	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	890	894	PGE2	PGE2	B-NP	NN	O	4	NMOD	O
O	O	895	902	release	release	I-NP	NN	O	2	OBJ	O
O	O	902	903	,	,	O	,	O	2	P	O
O	O	904	907	but	but	O	CC	O	2	VMOD	O
O	O	908	911	had	have	B-VP	VBD	O	2	VMOD	O
O	O	912	914	no	no	B-NP	DT	O	9	NMOD	O
O	O	915	924	influence	influence	I-NP	NN	O	7	OBJ	O
O	O	925	927	on	on	B-PP	IN	O	7	VMOD	O
O	O	928	931	the	the	B-NP	DT	O	13	NMOD	O
O	O	932	940	observed	observe	I-NP	VBN	O	13	NMOD	O
O	O	941	948	effects	effect	I-NP	NNS	O	10	PMOD	O
O	O	949	951	of	of	B-PP	IN	O	13	NMOD	O
T20	B-Protein	952	955	C3a	C3a	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	955	956	,	,	O	,	O	2	P	O
O	O	957	967	suggesting	suggest	B-VP	VBG	O	2	VMOD	O
O	O	968	972	that	that	B-SBAR	IN	O	17	VMOD	O
O	O	973	976	the	the	B-NP	DT	O	20	NMOD	O
O	O	977	984	effects	effect	I-NP	NNS	O	28	SUB	O
O	O	985	987	of	of	B-PP	IN	O	20	NMOD	O
T21	B-Protein	988	991	C3a	C3a	B-NP	NN	B-protein	21	PMOD	B-protein
O	O	992	994	on	on	B-PP	IN	O	20	NMOD	O
T22	B-Protein	995	997	IL	IL	B-NP	NN	B-protein	27	NMOD	B-protein
T22	I-Protein	997	998	-	-	O	HYPH	I-protein	27	NMOD	I-protein
T22	I-Protein	998	999	6	6	B-NP	CD	I-protein	27	NMOD	I-protein
O	O	1000	1010	production	production	I-NP	NN	O	23	PMOD	O
O	O	1011	1014	are	be	B-VP	VBP	O	18	SBAR	O
O	O	1015	1026	independent	independent	B-ADJP	JJ	O	28	PRD	O
O	O	1027	1029	of	of	B-PP	IN	O	29	AMOD	O
O	O	1030	1034	PGE2	PGE2	B-NP	NN	O	32	NMOD	O
O	O	1035	1044	formation	formation	I-NP	NN	O	30	PMOD	O
O	O	1045	1047	by	by	B-PP	IN	O	32	NMOD	O
O	O	1048	1057	monocytes	monocyte	B-NP	NNS	B-cell_type	33	PMOD	B-cell_type
O	O	1057	1058	.	.	O	.	O	2	P	O

O	O	1059	1067	Northern	Northern	B-NP	NN	O	3	NMOD	O
O	O	1068	1072	blot	blot	I-NP	NN	O	3	NMOD	O
O	O	1073	1081	analysis	analysis	I-NP	NN	O	4	SUB	O
O	O	1082	1088	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1089	1093	that	that	B-SBAR	IN	O	4	VMOD	O
T23	B-Protein	1094	1097	C3a	C3a	B-NP	NN	B-protein	14	SUB	B-protein
O	O	1098	1100	as	as	B-CONJP	RB	O	14	VMOD	O
O	O	1101	1105	well	well	I-CONJP	RB	O	7	DEP	O
O	O	1106	1108	as	as	I-CONJP	IN	O	7	DEP	O
T24	B-Protein	1109	1112	C3a	C3a	B-NP	NN	B-protein	12	NMOD	B-protein
T24	I-Protein	1112	1113	(	(	O	(	I-protein	12	NMOD	I-protein
T24	I-Protein	1113	1119	desArg	desArg	B-NP	NN	I-protein	14	SUB	I-protein
T24	I-Protein	1119	1120	)	)	O	)	I-protein	12	NMOD	I-protein
O	O	1121	1129	enhanced	enhance	B-VP	VBD	O	5	SBAR	O
O	O	1130	1133	LPS	LPS	B-NP	NN	O	19	NMOD	O
O	O	1133	1134	-	-	B-NP	HYPH	O	19	P	O
O	O	1134	1141	induced	induce	I-NP	VBN	O	19	NMOD	O
O	O	1142	1146	mRNA	mRNA	I-NP	NN	B-RNA	19	NMOD	B-RNA
O	O	1147	1153	levels	level	I-NP	NNS	O	14	OBJ	O
O	O	1154	1157	for	for	B-PP	IN	O	19	NMOD	O
T25	B-Protein	1158	1160	IL	IL	B-NP	NN	B-protein	22	NMOD	B-protein
T25	I-Protein	1160	1161	-	-	B-NP	HYPH	I-protein	20	PMOD	I-protein
T25	I-Protein	1161	1162	6	6	I-NP	CD	I-protein	22	NMOD	I-protein
O	O	1162	1163	.	.	O	.	O	4	P	O

O	O	1164	1176	Pretreatment	Pretreatment	B-NP	NN	O	7	SUB	O
O	O	1177	1179	of	of	B-PP	IN	O	1	NMOD	O
O	O	1180	1185	PBMCs	PBMC	B-NP	NNS	B-cell_type	2	PMOD	B-cell_type
O	O	1186	1190	with	with	B-PP	IN	O	1	NMOD	O
T31	B-Entity	1191	1200	pertussis	pertussis	B-NP	NN	B-protein	6	NMOD	B-protein
T31	I-Entity	1201	1206	toxin	toxin	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	1207	1214	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	1215	1218	the	the	B-NP	DT	O	9	NMOD	O
O	O	1219	1228	functions	function	I-NP	NNS	O	7	OBJ	O
O	O	1229	1231	of	of	B-PP	IN	O	9	NMOD	O
T26	B-Protein	1232	1235	C3a	C3a	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	1236	1239	and	and	O	CC	O	15	NMOD	O
T27	B-Protein	1240	1243	C3a	C3a	B-NP	NN	B-protein	15	NMOD	B-protein
T27	I-Protein	1243	1244	(	(	O	(	I-protein	15	NMOD	I-protein
T27	I-Protein	1244	1250	desArg	desArg	B-NP	NN	I-protein	10	PMOD	I-protein
T27	I-Protein	1250	1251	)	)	O	)	I-protein	15	NMOD	I-protein
O	O	1251	1252	,	,	O	,	O	7	P	O
O	O	1253	1263	indicating	indicate	B-VP	VBG	O	7	VMOD	O
O	O	1264	1268	that	that	B-SBAR	IN	O	18	VMOD	O
O	O	1269	1272	the	the	B-NP	DT	O	21	NMOD	O
O	O	1273	1280	actions	action	I-NP	NNS	O	26	SUB	O
O	O	1281	1283	of	of	B-PP	IN	O	21	NMOD	O
O	O	1284	1289	these	these	B-NP	DT	O	25	NMOD	O
O	O	1290	1293	two	two	I-NP	CD	O	25	NMOD	O
O	O	1294	1303	molecules	molecule	I-NP	NNS	O	22	PMOD	O
O	O	1304	1307	are	be	B-VP	VBP	O	19	SBAR	O
O	O	1308	1316	mediated	mediate	I-VP	VBN	O	26	VC	O
O	O	1317	1319	by	by	B-PP	IN	O	27	VMOD	O
O	O	1320	1321	a	a	B-NP	DT	O	31	NMOD	O
O	O	1322	1323	G	G	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	1324	1331	protein	protein	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	1331	1332	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	1332	1339	coupled	couple	I-NP	VBN	O	34	NMOD	O
O	O	1340	1347	pathway	pathway	I-NP	NN	O	28	PMOD	O
O	O	1347	1348	.	.	O	.	O	7	P	O

O	O	1349	1360	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	O
O	O	1360	1361	,	,	O	,	O	4	P	O
O	O	1362	1364	we	we	B-NP	PRP	O	4	SUB	O
O	O	1365	1377	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	1378	1381	the	the	B-NP	DT	O	6	NMOD	O
O	O	1382	1389	effects	effect	I-NP	NNS	O	4	OBJ	O
O	O	1390	1392	of	of	B-PP	IN	O	6	NMOD	O
T28	B-Protein	1393	1396	C3a	C3a	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	1397	1400	and	and	O	CC	O	12	NMOD	O
T29	B-Protein	1401	1404	C3a	C3a	B-NP	NN	B-protein	12	NMOD	B-protein
T29	I-Protein	1404	1405	(	(	O	(	I-protein	12	NMOD	I-protein
T29	I-Protein	1405	1411	desArg	desArg	B-NP	NN	I-protein	7	PMOD	I-protein
T29	I-Protein	1411	1412	)	)	O	)	I-protein	12	NMOD	I-protein
O	O	1413	1415	on	on	B-PP	IN	O	6	NMOD	O
O	O	1416	1425	induction	induction	B-NP	NN	O	14	PMOD	O
O	O	1426	1428	of	of	B-PP	IN	O	15	NMOD	O
T32	B-Entity	1429	1431	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T32	I-Entity	1431	1432	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T32	I-Entity	1432	1438	kappaB	kappaB	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	1439	1442	and	and	O	CC	O	25	NMOD	O
T33	B-Entity	1443	1453	activating	activate	B-NP	VBG	B-protein	22	NMOD	B-protein
T33	I-Entity	1454	1461	protein	protein	I-NP	NN	I-protein	25	NMOD	I-protein
T33	I-Entity	1461	1462	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T33	I-Entity	1462	1463	1	1	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	1464	1471	binding	binding	I-NP	NN	O	16	PMOD	O
O	O	1471	1472	.	.	O	.	O	4	P	O

O	O	1473	1477	Both	Both	B-NP	DT	O	2	NMOD	O
O	O	1478	1487	molecules	molecule	I-NP	NNS	O	3	SUB	O
O	O	1488	1496	enhanced	enhance	B-VP	VBD	O	0	ROOT	O
O	O	1497	1500	LPS	LPS	B-NP	NN	O	3	OBJ	O
O	O	1500	1501	-	-	O	HYPH	O	4	P	O
O	O	1501	1508	induced	induce	B-NP	VBN	O	4	NMOD	O
O	O	1509	1511	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	1511	1512	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
O	O	1512	1518	kappaB	kappaB	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	1519	1522	and	and	O	CC	O	16	NMOD	O
O	O	1523	1533	activating	activate	B-NP	VBG	B-protein	12	NMOD	B-protein
O	O	1534	1541	protein	protein	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	1541	1542	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
O	O	1542	1543	1	1	I-NP	CD	I-protein	16	NMOD	I-protein
O	O	1544	1551	binding	binding	I-NP	NN	O	16	NMOD	O
O	O	1552	1560	activity	activity	I-NP	NN	O	6	VMOD	O
O	O	1560	1561	.	.	O	.	O	3	P	O

O	O	1562	1567	These	These	B-NP	DT	O	2	NMOD	O
O	O	1568	1575	results	result	I-NP	NNS	O	3	SUB	O
O	O	1576	1587	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1588	1591	the	the	B-NP	DT	O	5	NMOD	O
O	O	1592	1600	capacity	capacity	I-NP	NN	O	3	OBJ	O
O	O	1601	1603	of	of	B-PP	IN	O	5	NMOD	O
O	O	1604	1610	intact	intact	B-NP	JJ	O	15	NMOD	O
T30	B-Protein	1611	1614	C3a	C3a	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	1615	1618	and	and	O	CC	O	12	NMOD	O
O	O	1619	1622	its	its	B-NP	PRP$	O	12	NMOD	O
O	O	1623	1634	circulating	circulate	I-NP	VBG	O	12	NMOD	O
O	O	1635	1638	des	de	I-NP	NNS	O	7	NMOD	O
O	O	1638	1639	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	1639	1642	Arg	Arg	I-NP	NN	O	15	NMOD	O
O	O	1643	1647	form	form	I-NP	NN	O	6	PMOD	O
O	O	1648	1650	to	to	B-VP	TO	O	17	VMOD	O
O	O	1651	1656	exert	exert	I-VP	VB	O	5	NMOD	O
O	O	1657	1672	immunmodulatory	immunmodulatory	B-NP	JJ	O	19	NMOD	O
O	O	1673	1680	effects	effect	I-NP	NNS	O	17	OBJ	O
O	O	1681	1683	in	in	B-ADVP	FW	O	17	VMOD	O
O	O	1684	1689	vitro	vitro	I-ADVP	FW	O	20	AMOD	O
O	O	1689	1690	.	.	O	.	O	3	P	O
